| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |